Therapeutic potential and mechanism of LECT2 for liver cancer
碩士 === 國立中山大學 === 生物醫學研究所 === 102 === Hepatocellular carcinoma (HCC) is one of the most common cancers in the world. However, current therapeutic modalities for HCC, including surgery, transendothelial embolization (TAE) and radiofrequency ablation (RFA), remain largely ineffectively. One major mech...
Main Authors: | Po-han Tai, 戴伯翰 |
---|---|
Other Authors: | Deng-chyang Wu |
Format: | Others |
Language: | en_US |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/66h94j |
Similar Items
-
The role of LECT2 in liver carcinogenesis
by: Ping-Hsuan Wu, et al.
Published: (2011) -
LECT2, A Novel and Direct Biomarker of Liver Fibrosis in Patients With CHB
by: Honghai Xu, et al.
Published: (2021-09-01) -
The Malay Lects of Southern Sumatra
by: Jonathan McDowell, et al.
Published: (2020-12-01) -
Numeral Systems in Various Fula Lects
by: Maria A. Kosogorova
Published: (2021-10-01) -
LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH
by: Noboru Takata, et al.
Published: (2021-01-01)